Characterizing systemic sclerosis in Northern California: Focus on Asian and Hispanic patients

Clinical and Experimental Rheumatology

Volumn 27, Issue 3 SUPPL. 54, 2009, Pages

  Schmajuk, Gabriela ^a   Bush, Thomas M ^a   Burkham, Jennifer ^a   Krishnan, Eswar ^a   Chung, Lorinda ^a  

^a NONE

Author keywords

Epidemiology; Race; Systemic sclerosis

Indexed keywords

ACETYLSALICYLIC ACID; BISPHOSPHONIC ACID DERIVATIVE; BOSENTAN; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYCHLOROQUINE; ILOPROST; METHOTREXATE; PENICILLAMINE; PREDNISONE; PROSTACYCLIN; PROTON PUMP INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SILDENAFIL; UNIPROST; VITAMIN D; WARFARIN;

ANEMIA; ARTHRALGIA; ARTICLE; ASIAN; CALCINOSIS; CAUCASIAN; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE DURATION; DYSPNEA; FEMALE; GANGRENE; GASTROESOPHAGEAL REFLUX; HEART ARRHYTHMIA; HISPANIC; HOME OXYGEN THERAPY; HUMAN; JOINT CONTRACTURE; LUNG FIBROSIS; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MYOSITIS; PERICARDIAL EFFUSION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RACE DIFFERENCE; RAYNAUD PHENOMENON; SJOEGREN SYNDROME; SKIN DISEASE; SYSTEMIC SCLEROSIS; TELANGIECTASIA; TUBERCULIN TEST; ULCER; UNITED STATES;

ADULT; AGE OF ONSET; ASIAN AMERICANS; ASIAN CONTINENTAL ANCESTRY GROUP; CALIFORNIA; COHORT STUDIES; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC;

EID: 70350317487     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. CHUNG L, LIN J, FURST DE, FIORENTINO D: Systemic and localized scleroderma. Clin Dermatol 2006; 24: 374-392
2. MCNEARNEY TA, REVEILLE JD, FISCHBACH M et al.: Pulmonary involvement in systemic sclerosis: Associations with genetic, serologic, sociodemographic, and behavioral factors. Arthritis Rheum 2007; 57: 318-326
3. BEALL AD, NIETERT PJ, TAYLOR MH et al.: Ethnic disparities among patients with pulmonary hypertension associated with systemic sclerosis. J Rheumatol 2007; 34: 1277-1282
4. LAING TJ, GILLESPIE BW, TOTH MB et al.: Racial differences in scleroderma among women in Michigan. Arthritis Rheum 1997; 40: 734-742
5. MAYES MD, LACEY JV, BEEBE-DIMMER J et al.: Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003; 48: 2246-2255
6. KRISHNAN E, FURST DE: Systemic sclerosis mortality in the United States: 1979-1998. Eur J Epidemiol 2005; 20: 855-861
7. REVEILLE JD, FISCHBACH M, MCNEARNEY T et al.: Systemic sclerosis in 3 US ethnic groups: A comparison of clinical, sociodemographic, serologic, and immunogenetic determinants. Semin Arthritis Rheum 2001; 30: 332-346
8. MCNEILAGE LJ, YOUNGCHAIYUD U, WHITTINGHAM S: Racial differences in antinuclear antibody patterns and clinical manifestations of scleroderma. Arthritis Rheum 1989; 32: 54-60.
9. PANICHEEWA S, CHITRABAMRUNG S, VERASERTNIYOM O et al.: Diffuse systemic sclerosis and related diseases in Thailand. Clin Rheumatol 1991; 10: 124-129
10. KUWANA M, KABURAKI J, ARNETT FC, HOWARD RF, MEDSGER TA, WRIGHT TM: Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody. Arthritis Rheum 1999; 42: 465-74.
11. NIETERT PJ, SILVERSTEIN MD, SILVER RM: Hospital admissions, length of stay, charges, and in-hospital death among patients with systemic sclerosis. J Rheumatol 2001; 28: 2031-2037
12. CHUNG L, KRISHNAN E, CHAKRAVARTY EF: Hospitalizations and mortality in systemic sclerosis: Results from the nationwide inpatient sample. Rheumatology 2007; 46: 1808-13.
13. HU PQ, FERTIG N, MEDSGER TA, WRIGHT TM: Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis. Arthritis Rheum 2003; 48: 1363-1373
14. STEEN VD, MEDSGER TA: The palpable tendon friction rub: An important physical examination finding in patients with systemic sclerosis. Arthritis Rheum 1997; 40: 1146-1151
15. VALENTINI G, MATUCCI CERINIC M: Disease-specific quality indicators, guidelines and outcome measures in scleroderma. Clin Exp Rheumatol 2007; 25 (Suppl. 47): 159-162
16. WEST CN, GEIGER AM, GREENE SM et al.: Race and ethnicity: Comparing medical records to self-reports. J Natl Cancer Inst Monogr 2005: 72-74